Apixaban shows effectiveness with or without warfarin therapy

08/5/2013 | TCTMD.com

A study in the American Heart Journal found that apixaban had the same effect on patients with atrial fibrillation whether or not they had been treated previously with warfarin. The subanalysis of the ARISTOTLE trial found that warfarin-naive patients treated with apixaban spent a median 61.4% time in therapeutic range, while those who had previously received warfarin were in therapeutic range a median 69.1% of treatment time. "In the present prospective comparison, prior [warfarin] exposure did not modify the effect of apixaban relative to warfarin for most key efficacy and safety outcomes," researchers wrote.

View Full Article in:

TCTMD.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI